Mount Sinai Health System

The Mount Sinai Health System is an integrated health care system providing exceptional medical care to their local and global communities.

Encompassing the Icahn School of Medicine at Mount Sinai and seven hospital campuses in the New York metropolitan area, as well as a large, regional ambulatory footprint, Mount Sinai is internationally acclaimed for its excellence in research, patient care, and education across a range of specialties. The Mount Sinai Health System was created from the combination of the Mount Sinai Medical Center and Continuum Health Partners, which both agreed unanimously to combine the two entities in July 2013.

The Health System is designed to increase efficiencies and economies of scale; improve quality and outcomes; and expand access to advanced primary, specialty, and ambulatory care services throughout a wide clinical network. The Health System includes more than 7,000 primary and specialty care physicians and 12 minority-owned free-standing ambulatory surgery centers. Mount Sinai also features a robust and continually expanding network of multispecialty services, including more than 45 ambulatory practices throughout the five boroughs of New York City, Westchester, and Long Island. It has more than 40 clinical and academic relationships with other local health care organizations. Mount Sinai physicians can be found in more than 300 community locations throughout the New York metropolitan area. With an extraordinary array of resources for the provision of compassionate, state-of-the-art care, the Mount Sinai Health System is poised to identify and respond to the health-related needs of the diverse populations they serve.

Mount Sinai Health System, established in 2013 and headquartered in New York, New York, United States, North America., specializes in Early Stage Venture, Seed, Late Stage Venture investments across Health Care, Biopharma, Medical Device, Neuroscience, Clinical Trials, Biotechnology, Life Science, Pharmaceutical, Health Diagnostics, Venture Capital. The organization boasts a portfolio of 4 investments, with an average round size of $11.9M and 2 successful exits. Their recent investments include Deliberate AI, PreciseDx, Agilent Technologies, Merck Global Health Innovation Fund, IBM Ventures. The highest investment round they participated in was $3.3B. Among their most notable exits are Deliberate AI and PreciseDx. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.